Add Formweb to your mobile device
Search results for:
RSV vaccine, preF A-preF B, recombinant (Abrysvo)
RSV vaccine, preF A-preF B, recombinant (Abrysvo)
Last updated: Jan. 29, 2026
- Restricted Formulary Restricted Medication
RSV vaccine, preF A-preF B, recombinant (Abrysvo)
Abrysvo is Outpatient Formulary, Restricted for maternal immunization in pregnant individuals 32-36 weeks.
Abrysvo is Inpatient Formulary, Restricted to PREGNANT individuals, weeks 32-36, who are admitted through delivery, with delivery anticipated to be ≥ 14 days out from vaccine administration.
See Arexvy and mRESVIA for formulary status of other RSV vaccines.